Skip to content
Trial Agents

Universitaetsklinikum Jena KöR

Universitaetsklinikum Jena KöR is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
10recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

Elotuzumab (E) in Combination with Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) versus KRd prior to and following Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma and Subsequent Maintenance with Elotuzumab and Lenalidomide versus Single-Agent Lenalidomide. A phase III study by DSMM (Deutsche Studiengruppe Multiples Myelom)

Sponsor Universitaetsklinikum Wuerzburg AöR

Start (EU)
Latest update
Estimated end
Not reported

Questions about this trial experience

What services are recorded for Universitaetsklinikum Jena KöR?

The 2026-10-09 snapshot links Universitaetsklinikum Jena KöR to 5 distinct CTIS trials. Recorded services include Clinical monitoring, Laboratory services, Project management, Regulatory services, among 10 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Universitaetsklinikum Jena KöR?

The most frequently recorded therapeutic areas are Haematological Malignancies, Infectious Disease. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Universitaetsklinikum Jena KöR conducted?

The linked trials record locations in 14 countries, including Germany, Austria, Belgium, Czechia, Estonia. These are trial locations, not confirmed office locations or countries where Universitaetsklinikum Jena KöR delivered services.

What can this page tell me about Universitaetsklinikum Jena KöR's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitaetsklinikum Jena KöR. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Universitaetsklinikum Jena KöR

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.